✦ LIBER ✦

Bevacizumab as front-line treatment for newly diagnosed epithelial cancer

✍ Scribed by González Martín, Antonio ;Bratos, Raquel ;Márquez, Raúl ;Alonso, Sonsoles ;Chiva, Luis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The expanding options for front-line tre

✍ Javier Pinilla-Ibarz; Ian Flinn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Measurements of adiposity as clinical bi

✍ Slaughter, Katrina N.; Thai, Theresa; Penaroza, Shayla; Benbrook, Doris M.; Thav 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Ascites predicts degree of treatment ben

✍ Ferriss, J.S.; Java, J.; Burger, R.A.; Bookman, M.A.; Fleming, G.; Monk, B.J.; W 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Systematic Review of First-Line Chemothe

✍ Allan Covens; Mark Carey; Peter Bryson; Shailendra Verma; Michael Fung Kee Fung; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Anti-VEGF antibody bevacizumab (Avastin)

✍ C. Emmanouilides; M. Pegram; R. Robinson; R. Hecht; F. Kabbinavar; W. Isacoff 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 63 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB